ABSTRACT
Stenocyphus Marshall, 1922 (Entiminae, Naupactini) includes three species: the type species S. bituberosus (Gyllenhal, 1833), S. tuberculatus (Hustache, 1938), comb. n. herein transferred from Neoericydeus Hustache, 1938, and S. sextuberosus sp. n. The genus is endemic to the Atlantic forests of the states of Espirito Santo, Rio de Janeiro and São Paulo, Brazil andis mainly characterized by the presence of humped elytra bearing large conical tubercles on the intervals 5, or 3 and 5, or 3, 5 and 7. It shares some external morphological characters with Hadropus Schoenherr, 1826 and the Brazilian species of Cyrtomon Schoenherr 1823, but its phylogenetic position is uncertain. Herein we provide a diagnostic key to separate Stenocyphus from those genera, generic and species redescriptions or descriptions, a key to species, habitus photographs, line drawings of genitalia, and a discussion of the patterns of elytral tubercles in unrelated genera of Neotropical broad-nosed weevils.
ABSTRACT
Traumatic fracture of unilateral genial tubercles and displacement to the mid-floor is rarely reported. These tubercles are attached to the geniohyoid and genioglossus muscles. Separation of these unilateral tubercles can lead to sublingual pain, dysfagia and difficulty in swallowing. A 28-year-old patient was admitted for sublingual pain. A fracture of the genial tubercle segment was discovered beneath the tongue. Surgical correction of this separated bone to allow it to return to its original position was performed without divulsion of the attached muscles. No evidence of complications from separated genial tubercles has been found after 3 years of follow-up.
Fratura traumática de tubérculos geni unilateral e deslocamento para o meio do assoalho bucal são raramente relatados. Esses tubérculos são presos pelos músculos genio-hioideo e genioglosso. A separação desses tubérculos unilaterais leva à dor sublingual, disfagia e dificuldade de deglutição. Paciente de 28 anos foi admitido devido à dor sublingual. A fratura do tubérculo geni foi descoberta debaixo da língua. A correção cirúrgica do osso fraturado pode ser feita sem a divulsão da musculatura anexa. Não há evidência de complicações de tubérculos geni não reduzidos após 3 anos de acompanhamento neste caso.
ABSTRACT
Tuberculosis (TB) is considered a public health problem in several countries. This disease is classified as either pulmonary or extrapulmonary. Within the extrapulmonary disease, ocular involvement is uncommon but it is important to recognize it because its incidence has been reported up to 1 percent. Ocular TB cases can be divided in primary and secondary. These manifestations can be caused by an active infection that invades the eye or by an immunologic reaction of delayed hypersensitivity in absence of the infectious agent. The most common clinical presentations are: chronic anterior uveitis, choroiditis and sclerokeratitis. Despite the existence of highly sensitive molecular diagnostic techniques, the diagnosis of ocular tuberculosis continues to be presumptive, based upon clinical presentation, systemic evaluation and response to treatment. For the treatment we use four drugs during a two month period (isoniazid, rifampin, pyrazinamide and ethambutol) and two drugs for four additional months.
La tuberculosis (TBC) es considerada un problema de salud pública en varios países del mundo. Esta enfermedad se clasifica en pulmonar y extra pulmonar. Dentro de la forma extra pulmonar, el compromiso ocular es poco común, pero es importante conocerlo ya que su incidencia puede llegar hasta 1 por ciento. Los casos de TBC ocular se dividen en primarios y secundarios. Las manifestaciones oculares pueden ser causadas por una infección activa que invade el ojo o por una reacción inmunológica de hipersensibilidad retardada, en ausencia del agente infeccioso. Las presentaciones más comunes son: uveítis anterior crónica, coroiditis y esclero-queratitis. A pesar de la existencia de herramientas moleculares altamente sensibles, el diagnóstico de TBC ocular continúa siendo presuntivo, basándose en la presentación clínica, evaluación sistémica y la respuesta terapéutica. Para el tratamiento se utilizan cuatro fármacos por dos meses (isoniacida, rifampicina, pirazinamida y etambutol) y dos fármacos por cuatro meses adicionales.